ISRCTN51223303
Completed
N/A
A prospective, single centre registry study recruiting consecutive patients to examine the safety, efficacy and subsequent incidence of cutaneous reaction with use of the Cook Flexor Radial Introducer Set
iverpool Heart and Chest Hospital NHS Foundation Trust (UK)0 sites415 target enrollmentOctober 17, 2013
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- iverpool Heart and Chest Hospital NHS Foundation Trust (UK)
- Enrollment
- 415
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients admitted for cardiac procedures with planned radial access
- •2\. Patients under the care of a participating consultant
Exclusion Criteria
- •1\. Patients under 18 years of age
- •2\. Patients unable to give informed consent
- •3\. Patients who feel unable or unwilling to return to the study centre for outcome measure assessment
- •4\. Patients who have had previous procedures through the same radial access site
- •5\. Emergency or high risk procedures with survival doubt
- •6\. Where there is a known sensitivity to the study device
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
A monocenter registry study to document clinical, biological and quality of life parameters in patients with gastrointestinal tumorsGastrointestinal tumorsCUP-SYNDROMC15-C26C80Malignant neoplasms of digestive organsMalignant neoplasm, without specification of siteDRKS00018788SLK-Kliniken Heilbronn GmbH450
Recruiting
N/A
A single-center prospective/retrospective registry database of patients with atrial fibrillation aiming to identify clinically applicable biomarkersAtrial fibrillationJPRN-UMIN000041762Juntendo University Hospital Department of Cardiovascular Biology and Medicine2,077
Not Yet Recruiting
Phase 3
Saroglitazar vs obeticholic acid in patients of fatty liver.Health Condition 1: K740- Hepatic fibrosisCTRI/2023/03/050213Department of Medical gastroenterology
Active, Not Recruiting
Phase 3
Efficacy and safety of Sirolimus granules twice daily administration in patients with intractuable vascular malformationsIntractable vascular malformationsVascular disordersD054079JPRN-jRCTs031200055Mochizuki Shinji11
Completed
N/A
Efficacy of Double Carbapenem regimen against Carbapenem resistant Enterobacteriaceae infectionsCTRI/2021/01/030762Roopali Somani46